Standart of care ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 96 | Crohn disease | 1 |
96. Crohn disease
Clinical trials : 2,442 / Drugs : 1,278 - (DrugBank : 248) / Drug target genes : 142 - Drug target pathways : 209
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04921033 (ClinicalTrials.gov) | March 1, 2021 | 4/6/2021 | Exclusive Enteral Nutrition in Patients With Ileocaecal Crohn's Disease | Exclusive Enteral Nutrition in Patients With Ileocaecal Crohn's Disease (XENIC): an Open-label, Multicenter, Prospective, Randomized Clinical Trial | Crohn Disease;Nutrient; Excess;Remission/Regression | Dietary Supplement: EEN (Nestle Modulen®);Drug: Standart of care | Duzce University | NULL | Recruiting | 18 Years | 75 Years | All | 256 | Phase 3 | Turkey |